SPT insider sale: 1,500 shares sold under 10b5-1 plan
Rhea-AI Filing Summary
Sprout Social CFO Joseph Del Preto reported the sale of 1,500 shares of Class A common stock on 10/07/2025 under a pre-existing 10b5-1 plan. The reported weighted-average sale price was $11.815 per share, with individual trade prices ranging from $11.68 to $12.01. After the sale, the reporting person beneficially owns 240,368 shares, held directly, which include multiple tranches of restricted stock units (RSUs) with scheduled vesting beginning 12/01/2025 and a separate tranche with 25% vesting on 03/01/2026, then quarterly thereafter. The filing was signed by an attorney-in-fact on 10/08/2025. No derivative transactions were reported.
Positive
- Sale executed under a 10b5-1 plan, indicating a pre-scheduled trade and reducing timing concerns
- Full disclosure of price range ($11.68–$12.01) and weighted-average price ($11.815)
Negative
- Large unvested RSU balance (240,368 shares total), which creates potential future selling pressure as tranches vest
- Immediate liquidity event by an executive, which may be viewed negatively by some investors despite plan protections
Insights
CFO executed a routine 10b5-1 sale of 1,500 shares at about $11.82.
The sale occurred under a 10b5-1 plan adopted on 08/20/2024, which provides an affirmative defense for scheduled insider trades and reduces the likelihood the trades were timed to undisclosed news. The reported weighted-average price was $11.815, with execution prices from $11.68 to $12.01.
The reporting person still holds 240,368 shares including RSUs that vest across multiple quarterly tranches beginning 12/01/2025 and a tranche with 25% vesting on 03/01/2026. Monitor upcoming vesting dates for potential future insider sales tied to vesting schedules within the next 12 months.
Significant portion of holdings are unvested RSUs with staggered schedules.
Of the 240,368 shares reported, multiple RSU tranches are detailed: sets vesting in 2, 6, 10, and a larger tranche with an initial 25% vest on 03/01/2026 followed by quarterly vesting. These vesting schedules affect when additional shares may become transferable and potentially sold.
For governance review, note the clear disclosure of the 10b5-1 plan adoption date (08/20/2024) and the attorney-in-fact signature on 10/08/2025; these are concrete items to reference when assessing insider sale policies and future dilution timing over the next year.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 1,500 | $11.815 | $18K |
Footnotes (1)
- This transaction occurred under a 10b5-1 plan adopted by the Reporting Person on August 20, 2024. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.68 to $12.01 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The total reported in column 5 includes: (1) 4,383 reported RSUs which vest in 2 equal quarterly installments beginning on December 1, 2025; (2) 15,237 reported RSUs which vest in 6 equal quarterly installments beginning on December 1, 2025; (3) 34,452 reported RSUs which vest in 10 equal quarterly installments beginning on December 1, 2025; and (4) 118,613 reported RSUs of which 25% will vest on March 1, 2026 with the remaining RSUs vesting in 12 equal quarterly installments beginning on June 1, 2026. Each RSU represents the contingent right to receive one share of Class A Common Stock of the Issuer and does not expire.
